However, the metastatic brain NEPC lesion had a significant enrichment of E2F and MYC targets, which are transcriptional profiles that reflect altered proliferation (E2F)25 or possibly drive neuroendocrine differentiation in prostate cancer (MYCN)26. This evidence concerns the gene MYCN and prostate carcinoma.